BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33218402)

  • 1. Cytoreductive surgery including distal pancreatectomy with splenectomy in advanced stage ovarian cancer: Two centers analysis.
    Erturk A; Kuru O; Akgor U; Boyraz G; Cakir C; Turan T; Ozgul N; Salman C; Yuce K
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):862-864. PubMed ID: 33218402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.
    Xiang L; Tu Y; He T; Shen X; Li Z; Wu X; Yang H
    J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-operative pancreatic fistula following splenectomy with or without distal pancreatectomy at cytoreductive surgery in advanced ovarian cancer.
    Bizzarri N; Korompelis P; Ghirardi V; O'Donnell RL; Rundle S; Naik R
    Int J Gynecol Cancer; 2020 Jul; 30(7):1043-1051. PubMed ID: 32546641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: A systematic review.
    Di Donato V; Bardhi E; Tramontano L; Capomacchia FM; Palaia I; Perniola G; Plotti F; Angioli R; Giancotti A; Muzii L; Panici PB
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):694-702. PubMed ID: 31806515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
    Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer.
    Nishikimi K; Tate S; Matsuoka A; Otsuka S; Shozu M
    J Gynecol Oncol; 2022 May; 33(3):e30. PubMed ID: 35128860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique.
    Macciò A; Sanna E; Lavra F; Chiappe G; Petrillo M; Madeddu C
    BMC Surg; 2021 Oct; 21(1):380. PubMed ID: 34711237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer.
    Yildirim Y; Sanci M
    Arch Gynecol Obstet; 2005 Jun; 272(1):31-4. PubMed ID: 15480722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery.
    Benedetti Panici P; Di Donato V; Fischetti M; Casorelli A; Perniola G; Musella A; Marchetti C; Palaia I; Berloco P; Muzii L
    Gynecol Oncol; 2015 Jun; 137(3):406-11. PubMed ID: 25824857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robotic-assisted laparoscopic splenectomy for recurrent ovarian cancer.
    Paterniti TA; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Aug; 30(8):1189-1194. PubMed ID: 32624496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Sep; 35(9):5097-101. PubMed ID: 26254413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-matched study.
    Qu L; Zhiming Z; Xianglong T; Yuanxing G; Yong X; Rong L; Yee LW
    Int J Surg; 2018 Jul; 55():81-86. PubMed ID: 29802919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.
    Kehoe SM; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; D'Angelica M; Jarnagin WR; Barakat RR; Chi DS
    Gynecol Oncol; 2009 Mar; 112(3):496-500. PubMed ID: 19091388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.
    Fotopoulou C; Jones BP; Savvatis K; Campbell J; Kyrgiou M; Farthing A; Brett S; Roux R; Hall M; Rustin G; Gabra H; Jiao L; Stümpfle R
    Arch Gynecol Obstet; 2016 Sep; 294(3):607-14. PubMed ID: 27040418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy at the time of primary or interval cytoreductive surgery for epithelial ovarian carcinoma: A review of outcomes.
    Rush SK; Lees BF; Huang DS; Peterson MF; Al-Niaimi A
    Gynecol Oncol; 2022 Nov; 167(2):283-288. PubMed ID: 36114028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Chemotherapy Increases R0 Cytoreduction Rate But Does Not Improve Final Outcome in Advanced Epithelial Ovarian Cancer.
    Medina-Franco H; Cortés-González R; Lambreton-Hinojosa F; Fimbres-Morales A; Vargas-Siordia JC
    Ann Surg Oncol; 2017 May; 24(5):1330-1335. PubMed ID: 27995454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique.
    Gallotta V; Nero C; Lodoli C; Chiantera V; Pacelli F; Fagotti A; Costantini B; Scambia G
    J Minim Invasive Gynecol; 2016; 23(3):425-8. PubMed ID: 26776676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
    Felsinger M; Minar L; Weinberger V; Rovny I; Zlamal F; Bienertova-Vasku J
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():154-160. PubMed ID: 29957400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy.
    Fagotti A; Gueli Alletti S; Corrado G; Cola E; Vizza E; Vieira M; Andrade CE; Tsunoda A; Favero G; Zapardiel I; Pasciuto T; Scambia G
    Int J Gynecol Cancer; 2019 Jan; 29(1):5-9. PubMed ID: 30640676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.